Peripheral neuropathy decisions — 2025

The Board granted a 100 percent rating for chronic renal disease with nephrolithiasis and hypertension from March 26, 2019, but no earlier.

The appeal for service connection for right and left lower extremity radiculopathy was withdrawn by the Veteran's authorized representative before a decision was made.

The Board granted service connection for bilateral lower extremity peripheral neuropathy, finding it is as likely as not due to military service exposure to herbicide agents.

The Board granted increased ratings for right and left lower extremity peripheral neuropathy, effective March 14, 2019, and a 10 percent rating for right and left hip limitation of extension, effective July 15, 2020. Other claims were denied.

The appeal was withdrawn by the Veteran, and therefore, no issues remain for appellate consideration.

The Veteran's service-connected disabilities of PTSD, CAD, and neuropathy are of sufficient severity to produce unemployability.

The Board granted service connection for left lower extremity neuropathy, right lower extremity neuropathy, and left shoulder degenerative arthritis and a partial-thickness bursal tendon tear, all related to herbicide agent exposure in service.

The Board remands the claims for higher initial ratings and TDIU due to service-connected diabetic neuropathies for further clarification of the Veteran's symptoms and their impact on his ability to work.

The Board granted service connection for a mental health disability, chronic headaches, and a low back disability. It also granted increased ratings for certain conditions but denied others.

The Board granted an earlier effective date of service connection for sleep apnea and granted increased ratings for diabetic peripheral neuropathy in the lower extremities. However, it denied earlier effective dates for other conditions and increased ratings for atrial fibrillation.

The Board denied the veteran's appeals for increased ratings and service connection, as the claims were not timely filed or the evidence did not support a nexus to service.

The Board remands the claims for further development, including a new VA examination to determine the nature and etiology of the Veteran's diabetes mellitus and diabetic peripheral neuropathies.

The Board denied service connection for diabetes mellitus, hypertension, and diabetic peripheral neuropathy in the upper extremities as they were not shown to be causally or etiologically related to any disease, injury, or incident during service, including exposure to contaminated water at Camp Lejeune.

The Board is remanding the claims for further development, including obtaining private treatment records and ensuring proper notification to the Veteran.

The Board denied service connection for diabetes mellitus Type II, left lower extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and thyroid cancer as there was no evidence of in-service incurrence or a causal relationship between the claimed conditions and the Veteran's military service.

The Board denied the Veteran's appeal for a compensable rating for ilio-inguinal neuropathy, due to hernia surgery.

The appeal for service connection for sleep apnea was granted, while other claims were denied or remanded. The low back disability claim was dismissed.

The Board granted service connection for benign neoplasm of the kidney and left lower extremity peripheral neuropathy as due to herbicide agent exposure.

The Board granted an initial disability rating of 40 percent for mononeuropathy of the right upper limb (major) and 30 percent for the left upper limb (minor), but denied an earlier effective date prior to August 10, 2022.

The Board granted service connection for prostate cancer and colon cancer, both related to the Veteran's exposure to contaminated water at Camp Lejeune. The back condition was denied as there is no evidence of a relationship between the current disability and service.